Making the case for ‘regulatory innovation’ in cancer research 02 Dec 2019 Regulation of new cancer therapies, whilst crucially important, can become a barrier to innovation. Our Policy Adviser, Roya Ziaie, takes a look at the current regulatory landscape and what is needed in the future to ensure innovative treatments find their way to patients as quickly as possible. Find out more Show/Hide